BioView Unveils Breakthrough Liquid Biopsy for HER2 Detection in Metastatic Breast Cancer
BioView’s liquid biopsy test offers a non-invasive method to detect HER2 status in metastatic breast cancer patients.
Read MorePosted by Andy Lundin | Dec 23, 2024 | Breast, Molecular Diagnostics |
BioView’s liquid biopsy test offers a non-invasive method to detect HER2 status in metastatic breast cancer patients.
Read MorePosted by Chris Wolski | Dec 20, 2024 | Analytical Software Systems |
Indica Labs has been selected by the University of Bern to deploy its HALO AP digital pathology platform in the cloud.
Read MorePosted by Andy Lundin | Dec 16, 2024 | Leukemia |
Researchers developed a groundbreaking blood test to personalize nanomedicine therapies for leukemia patients, improving treatments.
Read MorePosted by Andy Lundin | Dec 13, 2024 | Tuberculosis |
WHO granted prequalification to a tuberculosis molecular diagnostic test that delivers rapid detection of TB and drug resistance.
Read MorePosted by Andy Lundin | Dec 13, 2024 | Breast, Mass Spectrometry Instruments |
A new laser analysis and AI method capable of detecting stage 1a breast cancer with 98% accuracy offers an effective screening option.
Read More